Cargando…
HL156A, a novel pharmacological agent with potent adenosine-monophosphate-activated protein kinase (AMPK) activator activity ameliorates renal fibrosis in a rat unilateral ureteral obstruction model
BACKGROUND: Renal fibrosis is characterized by excessive production and deposition of extracellular matrix (ECM), which leads to progressive renal failure. Adenosine-monophosphate-activated protein kinase (AMPK) is a highly conserved kinase that plays a key role in Smad-3 signaling. Here, we examine...
Autores principales: | Tsogbadrakh, Bodokhsuren, Ju, Kyung Don, Lee, Jinho, Han, Miyeun, Koh, Junga, Yu, Yeonsil, Lee, Hajeong, Yu, Kyung-Sang, Oh, Yun Kyu, Kim, Hyo Jin, Ahn, Curie, Oh, Kook-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116936/ https://www.ncbi.nlm.nih.gov/pubmed/30161162 http://dx.doi.org/10.1371/journal.pone.0201692 |
Ejemplares similares
-
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016) -
The stable cyclic adenosine monophosphate analogue, dibutyryl cyclo-adenosine monophosphate (bucladesine), is active in a model of acute skin inflammation
por: Rundfeldt, Chris, et al.
Publicado: (2012) -
Roles of adenosine monophosphate-activated protein kinase (AMPK) in the kidney
por: Zhu, Na, et al.
Publicado: (2022) -
Cereblon contributes to the development of pulmonary fibrosis via inactivation of adenosine monophosphate-activated protein kinase α1
por: Kang, Hyo Jae, et al.
Publicado: (2021) -
Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells
por: Yamaguchi, Hiroshi, et al.
Publicado: (2014)